Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Research on Primary Progressive MS
Explaining Fingolimod’s Fatal Flaw
Corpus Callosum Cross-Section Correlated With Cognitive Decline
Antigen-Specific Therapy for MS Passes Safety Test
Human Brain and Spinal Fluid Resource Center
Physical Activity Associated With Improved Quality of Life in People With MS
Stopping Natalizumab May Increase Risk of MS Relapse
Coriell Cell Repositories
National Disease Research Interchange (NDRI)
PodBlog: B-Cell Double Header
NMDA Receptors May Modulate Severity of Multiple Sclerosis
MS Patient, Ph.D.: Calling Dr. Thomas Hale
BGC20-0134
Corticosteroids Ineffective for Many With Relapsing MS
Harvard Brain Tissue Resource Center
Genome-wide Study Brings MS Landscape Into Sharper Focus
Interferon β and Glatiramer Acetate Are Clinically Similar, Says Cochrane Meta-Analysis
Fatigue in MS Linked to Elevated Body Temperature
Phenytoin
Mellen Center MS Neurologist
Researchers Spill the Beans
Tracking Remyelination: Do You See What I See?
PML Death Associated With Tecfidera; FDA Issues Warning
Research Associate
Multiple Sclerosis Nurse Educator
Pages
« first
‹ previous
…
5
6
7
8
9
10
11
12
13
…
next ›
last »